Apellis Pharmaceuticals (APLS) Insider Trading & Ownership

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$47.51

-0.52 (-1.08%)

(As of 04/18/2024 ET)

Current Insider Ownership Percentage: 7.50%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 14
Amount Of Insider Selling (Last 12 Months): $53.66 M

Get APLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

APLS Insider Buying and Selling by Quarter

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Apellis Pharmaceuticals Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
4/8/2024	Pascal Deschatelets	Insider	Sell	69,107	$54.17	$3,743,526.19
4/1/2024	Timothy Eugene Sullivan	CFO	Sell	4,000	$58.66	$234,640.00
3/19/2024	A. Sinclair Dunlop	Director	Sell	18,681	$57.18	$1,068,179.58
3/18/2024	Mark Jeffrey Delong	Insider	Sell	9,913	$56.90	$564,049.70
3/15/2024	James George Chopas	CAO	Sell	184	$56.46	$10,388.64
3/13/2024	Nur Nicholson	Insider	Sell	11,220	$57.56	$645,823.20
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
3/1/2024	Cedric Francois	CEO	Sell	250,000	$64.11	$16,027,500.00
3/1/2024	Timothy Eugene Sullivan	CFO	Sell	6,000	$63.22	$379,320.00
2/12/2024	Adam J Townsend	Insider	Sell	1,148	$67.77	$77,799.96
2/12/2024	Cedric Francois	CEO	Sell	3,962	$67.77	$268,504.74
2/12/2024	David O Watson	General Counsel	Sell	781	$67.77	$52,928.37
2/12/2024	Timothy Eugene Sullivan	CFO	Sell	1,431	$67.77	$96,978.87
1/29/2024	Cedric Francois	CEO	Sell	2,843	$64.14	$182,350.02
1/29/2024	David O Watson	General Counsel	Sell	906	$64.14	$58,110.84
1/29/2024	Nur Nicholson	Insider	Sell	835	$64.14	$53,556.90
1/22/2024	Adam J Townsend	Insider	Sell	3,413	$65.00	$221,845.00
1/22/2024	Cedric Francois	CEO	Sell	13,431	$65.00	$873,015.00
1/22/2024	David O Watson	General Counsel	Sell	4,184	$65.00	$271,960.00
1/22/2024	James George Chopas	CAO	Sell	1,061	$65.00	$68,965.00
1/22/2024	Timothy Eugene Sullivan	CFO	Sell	3,551	$65.00	$230,815.00
1/16/2024	Cedric Francois	CEO	Sell	7,851	$66.81	$524,525.31
1/16/2024	David O Watson	General Counsel	Sell	4,240	$66.81	$283,274.40
1/16/2024	James George Chopas	CAO	Sell	864	$66.81	$57,723.84
1/16/2024	Jeffrey Eisele	Insider	Sell	438	$66.81	$29,262.78
1/16/2024	Timothy Eugene Sullivan	CFO	Sell	2,235	$66.81	$149,320.35
1/4/2024	Caroline Baumal	Insider	Sell	2,751	$60.05	$165,197.55
12/26/2023	Jeffrey Eisele	Insider	Sell	68	$57.86	$3,934.48
12/19/2023	David O Watson	General Counsel	Sell	3,905	$57.23	$223,483.15
12/1/2023	Lukas Scheibler	Insider	Sell	10,000	$60.00	$600,000.00
11/21/2023	Cedric Francois	CEO	Sell	5,000	$48.80	$244,000.00
11/17/2023	Alec Machiels	Director	Sell	1,250	$47.74	$59,675.00
11/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$47.27	$567,240.00
10/23/2023	James George Chopas	CAO	Sell	132	$46.04	$6,077.28
10/23/2023	Mark Jeffrey Delong	Insider	Sell	131	$46.04	$6,031.24
10/17/2023	Alec Machiels	Director	Sell	1,250	$48.50	$60,625.00
10/9/2023	Pascal Deschatelets	Insider	Sell	12,000	$40.38	$484,560.00
9/18/2023	Alec Machiels	Director	Sell	1,250	$45.00	$56,250.00
9/18/2023	Nur Nicholson	Insider	Sell	20,350	$44.27	$900,894.50
9/15/2023	Alec Machiels	Director	Sell	1,250	$45.34	$56,675.00
9/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$42.87	$514,440.00
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.
9/1/2023	Cedric Francois	CEO	Sell	150,000	$41.75	$6,262,500.00
8/31/2023	James George Chopas	CAO	Sell	551	$41.23	$22,717.73
8/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$23.66	$283,920.00
7/17/2023	Alec Machiels	Director	Sell	1,250	$64.79	$80,987.50
7/10/2023	Pascal Deschatelets	Insider	Sell	12,000	$84.55	$1,014,600.00
7/3/2023	David O Watson	General Counsel	Sell	8,510	$89.98	$765,729.80
7/3/2023	Timothy Eugene Sullivan	CFO	Sell	6,779	$89.97	$609,906.63
6/20/2023	Alec Machiels	Director	Sell	1,250	$88.41	$110,512.50
6/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$91.35	$1,096,200.00
6/5/2023	Timothy Eugene Sullivan	CFO	Sell	69,779	$88.80	$6,196,375.20
6/1/2023	Karen Lewis	Insider	Sell	5,000	$86.00	$430,000.00
5/17/2023	Alec Machiels	Director	Sell	1,250	$88.66	$110,825.00
5/16/2023	Cedric Francois	CEO	Sell	30,000	$85.66	$2,569,800.00
5/8/2023	Pascal Deschatelets	Insider	Sell	12,000	$92.39	$1,108,680.00
5/3/2023	Adam J Townsend	Insider	Sell	5,000	$82.71	$413,550.00
4/18/2023	Cedric Francois	CEO	Sell	30,000	$82.02	$2,460,600.00

(Data available from 1/1/2013 forward)

APLS Insider Trading Activity - Frequently Asked Questions

Who is on Apellis Pharmaceuticals's Insider Roster?: The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Caroline Baumal, Cedric Francois, David O Watson, Federico Grossi, James George Chopas, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Morningside Venture Investment, Nicole D Perry, Nur Nicholson, Pascal Deschatelets, Timothy Eugene Sullivan, and Victoria L Brown. Learn more on insiders at APLS.
What percentage of Apellis Pharmaceuticals stock is owned by insiders?: 7.50% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings.

Which Apellis Pharmaceuticals insiders have been selling company stock?: The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($3,862,164.97), Adam J Townsend ($4,014,794.96), Alec Machiels ($1,244,512.50), Caroline Baumal ($165,197.55), Cedric Francois ($32,763,087.07), David O Watson ($2,350,586.56), Federico Grossi ($766,850.00), James George Chopas ($165,872.49), Jeffrey Eisele ($192,963.30), Karen Lewis ($957,418.90), Lukas Scheibler ($1,030,000.00), Mark Jeffrey Delong ($2,605,190.94), Nur Nicholson ($1,600,274.60), Pascal Deschatelets ($15,591,126.19), Timothy Eugene Sullivan ($7,897,356.05), and Victoria L Brown ($121,410.00).
How much insider selling is happening at Apellis Pharmaceuticals?: Insiders have sold a total of 1,250,708 Apellis Pharmaceuticals shares in the last 24 months for a total of $75,328,806.08 sold.

More Insider Trading Tools from MarketBeat

Related Companies:

Insider Tracking Tools:

Insider Trading By Country:

Latest Articles:

This page (NASDAQ:APLS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Apellis Pharmaceuticals (APLS) Insider Trading & Ownership

APLS Insider Buying and Selling by Quarter

Apellis Pharmaceuticals Insider and Congressional Trades History

APLS Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apellis Pharmaceuticals (APLS) Insider Trading & Ownership

Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling Activity

APLS Insider Buying and Selling by Quarter

Apellis Pharmaceuticals Insider and Congressional Trades History

APLS Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat